Psychiatry and Neurology, Neurology · Tucson, AZ
NPI
1265486179
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2800 E Ajo Way
Tucson, AZ, 85713
Phone (520) 874-4700
Groups this clinician bills Medicare through
Medicare paid, 2024
$55K
2,183 services
Medicare patients, 2024
237
Average age 76
Drug cost, 2024
$879K
3,600 prescriptions
Company payments, 2025
$412
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott J Sherman was code 99214 (office e&m - established), 239 times for 153 patients. In total Scott J Sherman billed 2,183 services in 28 codes, and Medicare paid $55K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 239 | 153 | $75.41 | $18K |
| 99213 Office E&M - Established | Office | 136 | 97 | $50.09 | $6,812 |
| 99215 Office E&M - Established | Office | 77 | 68 | $104.99 | $8,084 |
| 64616 Musculoskeletal | Office | 43 | 17 | $67.97 | $2,923 |
| 99211 Office E&M - Established | Office | 32 | 24 | $7.77 | $249 |
| 99212 Office E&M - Established | Office | 28 | 23 | $30.53 | $855 |
| 64611 Musculoskeletal | Office | 25 | 11 | $85.01 | $2,125 |
| 99204 Office E&M - New | Office | 24 | 24 | $105.43 | $2,530 |
By year: 2022 $49K for 2,013 services; 2023 $47K for 2,005 services; 2024 $55K for 2,183 services.
Medicare prescription drug claims, 2024
In 2024, the drug Scott J Sherman prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 679 prescriptions and refills. In total Scott J Sherman wrote 3,600 Medicare prescriptions that cost $879K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 679 | 1,479 | 174 | $25K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 278 | 625 | 80 | $14K |
| Clonazepam Generic | 236 | 262 | 51 | $1,297 |
| Memantine Hcl Generic | 169 | 336 | 37 | $5,782 |
| Amantadine Amantadine Hcl | 142 | 303 | 45 | $8,327 |
| Donepezil Hcl Generic | 110 | 216 | 28 | $1,328 |
| Rasagiline Mesylate Generic | 108 | 260 | 26 | $25K |
| Gabapentin Generic | 104 | 231 | 27 | $2,995 |
| Ropinirole Hcl Generic | 93 | 207 | 24 | $4,652 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 93 | 208 | 26 | $2,883 |
| Quetiapine Fumarate Generic | 74 | 102 | 17 | $931 |
| Entacapone Generic | 73 | 170 | 27 | $18K |
| Carbidopa-Levodopa-Entacapone Carbidopa/Levodopa/Entacapone | 70 | 124 | 15 | $26K |
| Lorazepam Generic | 68 | 69 | 13 | $221 |
| Rivastigmine Generic | 65 | 101 | 18 | $16K |
Brand drugs: 381 claims; generic drugs: 3,219 claims; opioid claims: 73.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Scott J Sherman $412 ($412 in general payments such as food, travel and fees) from 5 companies. The largest payer was Abbvie Inc. with $180.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.